These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 15310279)

  • 1. New non-nucleoside inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Ivanov AV; Kozlov MV; Kuzyakin AO; Kostyuk DA; Tunitskaya VL; Kochetkov SN
    Biochemistry (Mosc); 2004 Jul; 69(7):782-8. PubMed ID: 15310279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-hepatitis C virus RdRp activity and replication of novel anilinobenzothiazole derivatives.
    Peng HK; Chen WC; Lin YT; Tseng CK; Yang SY; Tzeng CC; Lee JC; Yang SC
    Antiviral Res; 2013 Oct; 100(1):269-75. PubMed ID: 23994188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A fluorescence-based high-throughput screen to identify small compound inhibitors of the genotype 3a hepatitis C virus RNA polymerase.
    Eltahla AA; Lackovic K; Marquis C; Eden JS; White PA
    J Biomol Screen; 2013 Oct; 18(9):1027-34. PubMed ID: 23708123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to HCV nucleoside analogue inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Najera I
    Curr Opin Virol; 2013 Oct; 3(5):508-13. PubMed ID: 24070806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
    Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
    Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New pseudodimeric aurones as palm pocket inhibitors of Hepatitis C virus RNA-dependent RNA polymerase.
    Meguellati A; Ahmed-Belkacem A; Nurisso A; Yi W; Brillet R; Berqouch N; Chavoutier L; Fortuné A; Pawlotsky JM; Boumendjel A; Peuchmaur M
    Eur J Med Chem; 2016 Jun; 115():217-29. PubMed ID: 27017550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A homogeneous, solid-phase assay for hepatitis C virus RNA-dependent RNA polymerase.
    Wang YK; Rigat KL; Roberts SB; Gao M
    Anal Biochem; 2006 Dec; 359(1):106-11. PubMed ID: 17054898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research.
    Haudecoeur R; Peuchmaur M; Ahmed-Belkacem A; Pawlotsky JM; Boumendjel A
    Med Res Rev; 2013 Sep; 33(5):934-84. PubMed ID: 22893620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput docking for the identification of new influenza A virus polymerase inhibitors targeting the PA-PB1 protein-protein interaction.
    Tintori C; Laurenzana I; Fallacara AL; Kessler U; Pilger B; Stergiou L; Botta M
    Bioorg Med Chem Lett; 2014 Jan; 24(1):280-2. PubMed ID: 24314669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanism of a thumb domain hepatitis C virus nonnucleoside RNA-dependent RNA polymerase inhibitor.
    Howe AY; Cheng H; Thompson I; Chunduru SK; Herrmann S; O'Connell J; Agarwal A; Chopra R; Del Vecchio AM
    Antimicrob Agents Chemother; 2006 Dec; 50(12):4103-13. PubMed ID: 16940072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of PA endonuclease activity of influenza virus RNA polymerase by Kampo medicines.
    Shirayama R; Shoji M; Sriwilaijaroen N; Hiramatsu H; Suzuki Y; Kuzuhara T
    Drug Discov Ther; 2016; 10(2):109-13. PubMed ID: 26902927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the analysis of HCV NS5B RNA-dependent RNA polymerase.
    Lesburg CA; Radfar R; Weber PC
    Curr Opin Investig Drugs; 2000 Nov; 1(3):289-96. PubMed ID: 11249710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical characterization of a hepatitis C virus RNA-dependent RNA polymerase mutant lacking the C-terminal hydrophobic sequence.
    Tomei L; Vitale RL; Incitti I; Serafini S; Altamura S; Vitelli A; De Francesco R
    J Gen Virol; 2000 Mar; 81(Pt 3):759-67. PubMed ID: 10675414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA-dependent RNA polymerases from different hepatitis C virus genotypes reveal distinct biochemical properties and drug susceptibilities.
    May MM; Lorengel H; Kreuter J; Zimmermann H; Ruebsamen-Schaeff H; Urban A
    Biochim Biophys Acta; 2011 Oct; 1814(10):1325-32. PubMed ID: 21621653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of influenza PA-Nter endonuclease inhibitors using pharmacophore- and docking-based virtual screening.
    Ferro S; Gitto R; Buemi MR; Karamanou S; Stevaert A; Naesens L; De Luca L
    Bioorg Med Chem; 2018 Aug; 26(15):4544-4550. PubMed ID: 30082105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitors.
    Xu HT; Hassounah SA; Colby-Germinario SP; Oliveira M; Fogarty C; Quan Y; Han Y; Golubkov O; Ibanescu I; Brenner B; Stranix BR; Wainberg MA
    J Antimicrob Chemother; 2017 Mar; 72(3):727-734. PubMed ID: 28069884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Respiratory Syncytial Virus Inhibitor AZ-27 Differentially Inhibits Different Polymerase Activities at the Promoter.
    Noton SL; Nagendra K; Dunn EF; Mawhorter ME; Yu Q; Fearns R
    J Virol; 2015 Aug; 89(15):7786-98. PubMed ID: 25995255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations conferring resistance to a hepatitis C virus (HCV) RNA-dependent RNA polymerase inhibitor alone or in combination with an HCV serine protease inhibitor in vitro.
    Mo H; Lu L; Pilot-Matias T; Pithawalla R; Mondal R; Masse S; Dekhtyar T; Ng T; Koev G; Stoll V; Stewart KD; Pratt J; Donner P; Rockway T; Maring C; Molla A
    Antimicrob Agents Chemother; 2005 Oct; 49(10):4305-14. PubMed ID: 16189112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.
    Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides.
    Tomei L; Altamura S; Bartholomew L; Bisbocci M; Bailey C; Bosserman M; Cellucci A; Forte E; Incitti I; Orsatti L; Koch U; De Francesco R; Olsen DB; Carroll SS; Migliaccio G
    J Virol; 2004 Jan; 78(2):938-46. PubMed ID: 14694125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.